ABBV: EC Approves SKYRIZI
AbbVie's SKYRIZI is approved by the European Commission for children and adolescents with moderate to severe plaque psoriasis
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.